It is not CMS's job to second guess the drug approvals of the FDA.

I just do not understand CMS's misguided and outright unprecedented decision to not cover a whole class of Alzheimer's drugs.

There is no safer place in the U.S. banking system to put your deposits.

We are going to be, shortly, reintroducing that bipartisan bill. It proposes critical reforms to increase the effectiveness and impact of USAID's maternal and child survival programs.

Furthermore, 200 Alzheimer's researchers have also written to CMS, and said there is no question, but that this drug should be allowed for patients who are receiving Medicare.

I want to express directly, too, my deep concern and disappointment about that agreement.

It is just extremely frustrating, as is the fact that the President's budget does not provide additional funding, specifically targeting Alzheimer's research.

I am disappointed that I haven't received an answer to that letter which was sent more than a month ago.

Thank you very much, Chairman Coons. I am delighted to join you today.

families, of course, are also counting on us to raise the debt limit, you just talked about this, without drama, without delay.

CMS needs to stay in its lane. FDA is in charge of drug approval, not CMS.

the IRS is now answering 90 percent of its phone calls. That is a dramatic improvement from the 13 percent last year.

Strong funding for Treasury means strong enforcement of our sanctions against Russia and Iran, the drug cartels, and other dangerous actors.

families, of course, are also counting on us to raise the debt limit, you just talked about this, without drama, without delay.

I also think that there is a very interesting debate on the best way to help people around the world who are struggling with hunger: Is it to provide them with food, or is it to teach them how to grow their own food, so that they can…

Now, some of our colleagues, including Senator Elizabeth Warren, has recommended that we raise up to $2 million or even up to $10 million.

I don't know what more evidence you could need than a Stage III clinical trial.

How anyone could be shocked that the Taliban resumed its extraordinary harsh measures against children, and against girls and women, is beyond me.